In Part A, children who received a higher dose of Dupixent (n=37) based on a weight-based dosing regimen experienced the following outcomes, compared to placebo (n=34) at 16 weeks: 68% achieved ...

METREX involved patients with a range of eosinophil levels and showed a ... label extended to include chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis ...

In Part A, children who received a higher dose of Dupixent (n=37) based on a weight-based dosing regimen experienced the following outcomes, compared to placebo (n=34) at 16 weeks: 68% achieved ...

In some cases, COPD can produce increased levels of white blood cells called eosinophils. Symptoms of COPD include: Dupixent is used to treat chronic rhinosinusitis with nasal polyps in adults and ...

Nasal polyps are small noncancerous growths in the nose or sinuses. They may cause pain or pressure in the face, runny or stuffy nose, and other symptoms or complications that may negatively ...

An infiltration of >30 eosinophils per high-power field in at least five high-power fields, exhibiting signs of eosinophilic degranulation and extending to the muscularis mucosa or submucosa are ...

Eosinophilic asthma (also known as e-asthma or eos asthma) is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune ...

Cause of Elevated Eosinophils "Eosinophilia" is the term used to describe an abnormally high eosinophil count. Lab values can vary, but an eosinophil count of less than 500 cells per microliter of ...

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN) and Amgen (NASDAQ:AMGN) have announced positive outcomes from the Phase III WAYPOINT trial of TEZSPIRE (tezepelumab) for patients with severe chronic ...